Skip to contentP
Pure Bioscience, Inc.
P
PUREPure Bioscience, Inc. Q1 2016 · 10-Q
Revenue$186.00K$186.00K+59.0% vs Q1 2015 Net Income-$2.82M-$2.82MN/M vs Q1 2015 EPS Diluted-$0.07-$0.07N/M vs Q1 2015 Operating Income-$1,862,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Pure Bioscience, Inc. · CIK 1006028 · Engraved from SEC EDGAR
Margins · derivedOperating margin-1001.1%+648.5 pt vs Q1 2015
Net margin-1516.1%+136.9 pt vs Q1 2015
ended Oct 31, 2015 · filed Dec 10, 2015 · 40 d after period end